Goldman Sachs Group Inc Lucid Diagnostics Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 63,575 shares of LUCD stock, worth $97,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,575Holding current value
$97,905% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding LUCD
# of Institutions
35Shares Held
3.39MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.02MShares$1.57 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$863,8090.0% of portfolio
-
Sargent Investment Group, LLC542KShares$833,9100.07% of portfolio
-
Geode Capital Management, LLC Boston, MA280KShares$430,4360.0% of portfolio
-
Lido Advisors, LLC Los Angeles, CA140KShares$215,6240.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $59.4M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...